Fractionated Blood Disorders Day Series

Description

This series is presented in cooperation with the Community Oncology Program at CancerCare Manitoba. (Since this is a series, you only need to register once)

Throughout this series, local hematologists will lead educational sessions and provide practical and relevant information on topics related to the workup and management of blood disorders in a primary care setting.

Learning Objectives for the series

1. Develop an approach to the work up of patients with suspected blood disorders, especially those with laboratory abnormalities (e.g. anemia or other cytopenias).
2. Use clinical algorithms to inform the diagnosis, management, and optimal referral of patients with blood disorders.
3. Review up to date treatment strategies for patients with common blood disorders.

UM_RFHS_CPD Fractionated BDD Poster

May 1, 2020 – 12:00 Noon to 1:00 pm

Overall Presentation: The Iron Chefs: Serving up high quality care in the setting of iron deficiency and overload

Learning Objectives:

• Explain the mechanisms by which the body regulates iron homeostasis, and how defects can lead to iron overload
• Use simple tests (iron, TIBC, and ferritin) to sort out disorders of altered iron status
• Apply strategies to manage iron deficiency and iron overload

Presenters:
Part 1 – Iron Homeostasis, Iron Overload, and Laboratory Measures of Iron
Donald Houston, MD, FRCPC
Hematologist, CancerCare Manitoba
Affiliate Investigator, Research Institute of Oncology and Hematology, CancerCare Manitoba
Associate Professor, Department of Internal Medicine, Section of Haematology/Oncology, University of Manitoba

Part 2 – Iron Deficiency Anemia (IDA): It’s easy as 1,2,3
Emily Rimmer, MD, FRCPC
Hematologist, CancerCare Manitoba
Assistant Professor, Department of Internal Medicine, Section of Haematology/Oncology, University of Manitoba

May 22, 2020 – 12:00 Noon to 1:00 pm

Title: MGUS & Myeloma

Learning Objectives

• Describe indications for ordering a serum protein electrophoresis (SPEP) and free light chain ratio and how to interpret results
• Distinguish MGUS from multiple myeloma and other plasma cell dyscrasias.
• Summarize current treatment options and prognosis for multiple myeloma in 2020

Presenters:

Mark Kristjanson, MD, CFPC
Primary Care Lead, CancerCare Manitoba
Presentation: MGUS & Myeloma

Arvand Barghi, MD, FRCPC
Currently completing hematology subspecialty residency
Presentation: Laboratory Testing of Monoclonal Gammopathy

Vi Dao, MD, FRCPC
Hematologist, CancerCare Manitoba
Assistant Professor, Department of Internal Medicine, Section of Haematology/Oncology, University of Manitoba

Study Credits

This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been approved by the CPD Medicine Program, University of Manitoba for up to 1.0 Mainpro+ credits.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved by the CPD Medicine Program, University of Manitoba for a maximum of 1.0 hours per session.
Participants should only claim credit for the actual number of hours attended.